DK1315721T3 - Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel - Google Patents

Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel

Info

Publication number
DK1315721T3
DK1315721T3 DK01963244T DK01963244T DK1315721T3 DK 1315721 T3 DK1315721 T3 DK 1315721T3 DK 01963244 T DK01963244 T DK 01963244T DK 01963244 T DK01963244 T DK 01963244T DK 1315721 T3 DK1315721 T3 DK 1315721T3
Authority
DK
Denmark
Prior art keywords
antidiabetic agent
compound
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
DK01963244T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1315721T3 publication Critical patent/DK1315721T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK01963244T 2000-09-07 2001-09-05 Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel DK1315721T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021978.2A GB0021978D0 (en) 2000-09-07 2000-09-07 Novel pharmaceutical
PCT/GB2001/003979 WO2002020517A1 (en) 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
DK1315721T3 true DK1315721T3 (da) 2007-02-19

Family

ID=9899043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01963244T DK1315721T3 (da) 2000-09-07 2001-09-05 Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel

Country Status (15)

Country Link
US (1) US20040014791A1 (da)
EP (1) EP1315721B1 (da)
JP (1) JP2004508367A (da)
KR (1) KR100769007B1 (da)
CN (2) CN100415741C (da)
AT (1) ATE343574T1 (da)
AU (1) AU2001284274A1 (da)
CY (1) CY1105903T1 (da)
DE (1) DE60124119T2 (da)
DK (1) DK1315721T3 (da)
ES (1) ES2272528T3 (da)
GB (1) GB0021978D0 (da)
HK (1) HK1057204A1 (da)
PT (1) PT1315721E (da)
WO (1) WO2002020517A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
KR20010043455A (ko) * 1998-06-30 2001-05-25 다케다 야쿠힌 고교 가부시키가이샤 당뇨병 치료용 약학적 조성물

Also Published As

Publication number Publication date
AU2001284274A1 (en) 2002-03-22
KR20030031179A (ko) 2003-04-18
GB0021978D0 (en) 2000-10-25
CN1814599A (zh) 2006-08-09
KR100769007B1 (ko) 2007-10-22
CY1105903T1 (el) 2011-02-02
HK1057204A1 (en) 2004-03-19
ATE343574T1 (de) 2006-11-15
DE60124119D1 (de) 2006-12-07
EP1315721B1 (en) 2006-10-25
ES2272528T3 (es) 2007-05-01
CN100415741C (zh) 2008-09-03
PT1315721E (pt) 2007-01-31
JP2004508367A (ja) 2004-03-18
US20040014791A1 (en) 2004-01-22
DE60124119T2 (de) 2007-05-16
EP1315721A1 (en) 2003-06-04
CN1471530A (zh) 2004-01-28
WO2002020517A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
AP1813A (en) Tartrate salts of thiazolidinedione derivative.